Radaeva et al.18 showed that IL-22 blockade reduced STAT3 activation and exacerbated liver injury in T cell-mediated hepatitis, whereas injection of IL-22 attenuates the injury. The gene discussed is IL22; the disease is hepatitis A virus infection.